Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Umberto Vitolo

Showing results (41-50 of 212) with videos related to

Pageof 22
Sort By:
Leukemia & Lymphoma|February 25, 2014
The more patients you treat, the more you cure: managing cardiotoxicity in the treatment of aggressive non-Hodgkin lymphomaPier Luigi Zinzani, Massimo Federico, Stefano Oliva, et al.
British Journal of Haematology|October 29, 2015
Safety and efficacy of ruxolitinib in myelofibrosis patients without splenomegalyFrancesca Palandri, Nicola Polverelli, Massimo Breccia, et al.
International Journal of Cancer|November 6, 2003
Thymic function and immunoglobulin mutation genotype in B-cell chronic lymphocytic leukemia patientsElena Nardini, Francesca Neri, Elisa Vicenzi, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 22, 2015
Brentuximab Vedotin in CD30-Positive Lymphomas: A SIE, SIES, and GITMO Position PaperPier Luigi Zinzani, Paolo Corradini, Alessandro M Gianni, et al.
American Journal of Hematology|January 23, 2010
Consensus conference on the use of 90-yttrium-ibritumomab tiuxetan therapy in clinical practice. A project of the Italian society of hematologyUmberto Vitolo, Giovanni Barosi, Stefano Fanti, et al.
Cancer|June 24, 2010
Oxaliplatin-based chemotherapy (dexamethasone, high-dose cytarabine, and oxaliplatin)±rituximab is an effective salvage regimen in patients with relapsed or refractory lymphomaLuigi Rigacci, Alberto Fabbri, Benedetta Puccini, et al.
Future Oncology (London, England)|July 20, 2022
Obinutuzumab in the treatment of B-cell malignancies: a comprehensive reviewAndrew Davies, Arnon P Kater, Jeff P Sharman, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2016
Prognostic Role of Pre-Radiation Therapy (18)F-Fluorodeoxyglucose Positron Emission Tomography for Primary Mediastinal B-Cell Lymphomas Treated with R-CHOP or R-CHOP-Like Chemotherapy Plus RadiationAndrea Riccardo Filippi, Cristina Piva, Mario Levis, et al.
Leukemia & Lymphoma|October 11, 2011
Overview of alemtuzumab therapy for the treatment of T-cell lymphomasPier Luigi Zinzani, Paolo Corradini, Andrea Gallamini, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 6, 2026
The Prognostic Role of Interim [18F]FDG PET/CT in Diffuse Large B-Cell Lymphoma: An Updated Systematic Review and Meta-analysisDomenico Albano, Stephane Chauvie, Alessio Rizzo, et al.
Pageof 22

Showing results (41-50 of 212) with videos related to

Sort By:
Pageof 22
Leukemia & Lymphoma|February 25, 2014
The more patients you treat, the more you cure: managing cardiotoxicity in the treatment of aggressive non-Hodgkin lymphomaPier Luigi Zinzani, Massimo Federico, Stefano Oliva, et al.
British Journal of Haematology|October 29, 2015
Safety and efficacy of ruxolitinib in myelofibrosis patients without splenomegalyFrancesca Palandri, Nicola Polverelli, Massimo Breccia, et al.
International Journal of Cancer|November 6, 2003
Thymic function and immunoglobulin mutation genotype in B-cell chronic lymphocytic leukemia patientsElena Nardini, Francesca Neri, Elisa Vicenzi, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 22, 2015
Brentuximab Vedotin in CD30-Positive Lymphomas: A SIE, SIES, and GITMO Position PaperPier Luigi Zinzani, Paolo Corradini, Alessandro M Gianni, et al.
American Journal of Hematology|January 23, 2010
Consensus conference on the use of 90-yttrium-ibritumomab tiuxetan therapy in clinical practice. A project of the Italian society of hematologyUmberto Vitolo, Giovanni Barosi, Stefano Fanti, et al.
Cancer|June 24, 2010
Oxaliplatin-based chemotherapy (dexamethasone, high-dose cytarabine, and oxaliplatin)±rituximab is an effective salvage regimen in patients with relapsed or refractory lymphomaLuigi Rigacci, Alberto Fabbri, Benedetta Puccini, et al.
Future Oncology (London, England)|July 20, 2022
Obinutuzumab in the treatment of B-cell malignancies: a comprehensive reviewAndrew Davies, Arnon P Kater, Jeff P Sharman, et al.
International Journal of Radiation Oncology, Biology, Physics|May 1, 2016
Prognostic Role of Pre-Radiation Therapy (18)F-Fluorodeoxyglucose Positron Emission Tomography for Primary Mediastinal B-Cell Lymphomas Treated with R-CHOP or R-CHOP-Like Chemotherapy Plus RadiationAndrea Riccardo Filippi, Cristina Piva, Mario Levis, et al.
Leukemia & Lymphoma|October 11, 2011
Overview of alemtuzumab therapy for the treatment of T-cell lymphomasPier Luigi Zinzani, Paolo Corradini, Andrea Gallamini, et al.
Clinical Lymphoma, Myeloma & Leukemia|July 6, 2026
The Prognostic Role of Interim [18F]FDG PET/CT in Diffuse Large B-Cell Lymphoma: An Updated Systematic Review and Meta-analysisDomenico Albano, Stephane Chauvie, Alessio Rizzo, et al.
Pageof 22